3B BlackBio Dx Ltd. News And Announcements

16:01 May 20

3B BlackBio Dx Ltd.

Sector Chemicals & Petrochemicals Industry Agrochemicals
Up
1693.65
-6.10 (-0.36%)
Sector Chemicals & Petrochemicals Industry Agrochemicals

3B BlackBio Dx Ltd. News And Announcements

3B BlackBio Dx Ltd.

Sector Chemicals & Petrochemicals
Industry Agrochemicals
Up
1693.65
-6.10 (-0.36%)
16:01 May 20
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

31/100
Mid Valuation

Technical

44/100
Technically Neutral

Strength

6

Weakness

4

Opportunity

0

Threats

0

1.45K

Market Cap (Cr)

-

PE Ratio

5.89

Price to Book Ratio

46.61

RSI

43.30 %

Net Profit Margin

News

Announcement

  • 19 May 2025

    Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter / Financial Year Ended March 31 2025 And To Discuss The Matter Of Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter /financial year ended March 31 2025... More>

  • 12 May 2025

    Intimation To The Holders Of Physical Securities To Furnish KYC Details

    Intimation to the holders of Physical Securities to furnish KYC details

  • 30 Apr 2025

    Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015

    Intimation under Regulation 30 of SEBI (LODR) Regulations 2015

  • 15 Apr 2025

    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company 3B BlackBio Dx Ltd 2 CIN NO. L24211MP1972PLC001131 ... More>

  • 11 Apr 2025

    COMPLIANCE CERTIFICATE UNDER REGULATION 40(9) OF SEBI (LODR) REGULATIONS 2015 FOR THE YEAR ENDED 31-03-2025.

    Compliance Certificate under Reg 40(9) of SEBI (LODR) Regulations 2015 for the year ended 31-03-2025

  • 11 Apr 2025

    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of Company3B BlackBio Dx Ltd 2CIN NO.L24211MP1972PLC001131 3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs... More>

  • 09 Apr 2025

    Non Applicability Of Statement Of Deviation Or Variation Under Reg. 32(1) Of SEBI (LODR) Regulations 2015

    Non-Applicability of Statement of Deviation or variation under Reg. 32 (1) of SEBI (LODR) Regulations 2015

  • 03 Apr 2025

    Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011

    Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011

  • 25 Mar 2025

    Closure of Trading Window

    Closure of Trading Window

  • 24 Mar 2025

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mahesh Kumar Upadhyay

  • 22 Mar 2025

    Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011

    Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011

  • 03 Sep 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Advertisement

  • 02 Sep 2024

    Announcement under Regulation 30 (LODR)-Dividend Updates

    Dividend updates

  • 02 Sep 2024

    Reg. 34 (1) Annual Report.

    Annual Report for the FY 2023-24

  • 02 Sep 2024

    Notice Of 52Nd Annual General Meeting To Be Held On 24Th September2024

    Notice of 52nd Annual General meeting to be held on 24th September 2024

  • 02 Sep 2024

    52Nd Annual General Meeting On Tuesday 24Th September 2024

    52nd Annual General Meeting on Tuesday 24th September 2024

  • 02 Sep 2024

    Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM

    Record Date and date of Book Closure for the purpose of Dividend and AGM

  • 28 Aug 2024

    Shareholders Update

    Shareholders Update

  • 24 Aug 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Publication

  • 23 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 22 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of duplicate share certificate under Reg 39 (3) of SEBI (LODR) Regulations 2015

  • 22 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 21 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 21 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 17 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 13 Aug 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2024

  • 12 Aug 2024

    Unaudited Standalone And Consolidated Financial Results For Quarter Ended 30-06-24

    Unaudited Standalone and Consolidated Financial Results for quarter ended 30-06-24

  • 12 Aug 2024

    Board Meeting Outcome for Outcome Of Board Meeting Dt 12-08-2024

    Outcome of Board Meeting dt 12-08-2024

  • 12 Aug 2024

    Intimation Of Notice To Shareholders For Transfer Of Equity Shares To The Investor Education And Pro

    Intimation of Notice to Shareholders for transfer of Equity Shares to the Investor Education and Protection Fund (IEPF) Authority.

  • 12 Aug 2024

    Announcement under Regulation 30 (LODR)-Investor Presentation

    Investors Presentation

  • 10 Aug 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Disclosure under Regulation 30 of SEBI (LODR) Regulations2015-Newspaper Publication

  • 05 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 01 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 30 Jul 2024

    Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the company for the first quarter ended on 30th... More>

  • 09 Jul 2024

    Intimation To Holders Of Physical Securities To Furnish PAN KYC Details And Nomination As Per SEBI C

    Intimation to holders of physical securities to furnish PANKYC details and Nomination as per SEBI Circular

  • 05 Jul 2024

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

    Certificate under Reg 74(5) of SEBI (DP) Regulations2018

  • 04 Jul 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 28 Jun 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Details of Loss of Certificate/Duplicate Certificate

  • 28 Jun 2024

    Closure of Trading Window

    Closure of Trading Window

  • 13 Jun 2024

    Clarification On Price Movement

    Clarification on Price Movement

  • 13 Jun 2024

    Clarification sought from 3B BlackBio Dx Ltd

    The Exchange has sought clarification from 3B BlackBio Dx Ltd on June 12 2024 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the... More>

  • 30 May 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Publication of Extract of Audited Financial Results for quarter and year ended 31-03-2024

  • 30 May 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Publication of Extract of Audited Financial Results for the quarter and year ended 31-03-2024

  • 29 May 2024

    Submission Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31 M

    Submission of Audited Financial Results for the Quarter and Financial Year ended 31st March2024

  • 29 May 2024

    Board Meeting Outcome for Outcome Of BM

    Outcome of BM

  • 29 May 2024

    Announcement under Regulation 30 (LODR)-Dividend Updates

    Dividend update

  • 29 May 2024

    Announcement under Regulation 30 (LODR)-Dividend Updates

    Dividend update

  • 29 May 2024

    Board Meeting Outcome for Outcome Of BM

    Outcome of BM

  • 29 May 2024

    Investor Presentation

    Investor Presentation

  • 27 May 2024

    Compliances-Reg.24(A)-Annual Secretarial Compliance

    Annual Secretarial Compliance Report for the year ended 31-03-2024.

  • 09 May 2024

    Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015.

    Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015.

  • 02 May 2024

    Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31 2024 .

  • 27 Apr 2024

    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company 3B BlackBio Dx Ltd 2 CIN NO. L24211MP1972PLC001131 ... More>

  • 27 Apr 2024

    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of Company3B BlackBio Dx Ltd 2CIN NO.L24211MP1972PLC001131 3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs... More>

  • 15 Apr 2024

    Submission Of Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations 2015 For

    Submission of compliance certificate under Regulation 40(9) of the SEBI (LODR) Regulations 2015 for the financial year ended 31-03-2024

  • 08 Apr 2024

    Disclosure Under Reg 32(1) Of SEBI (LODR) Regulations2015

    Disclosure under Reg 32(1) of SEBI (LODR) Regualtions2015

  • 05 Apr 2024

    Compliance Certificate- Regulation 7(3) OF SEBI (LODR) Regulations 2015.

    Compliance Certificate - Regulation 7 (3) of SEBI (LODR) Regulations 2015

  • 05 Apr 2024

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

    Certificate under Reg. 74 (5) of the SEBI (DP) Regulations 2018

  • 02 Apr 2024

    Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011

    Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011

  • 27 Mar 2024

    Closure of Trading Window

    Closure of Trading Window

  • 13 Mar 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of Duplicate share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 01 Mar 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding Loss of Share Certificates under Regulation 39(3) of SEBI (LODR) 2015

  • 10 Feb 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December2023.

  • 09 Feb 2024

    Investors Presentation

    Investors Presentation

  • 09 Feb 2024

    Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2023.

    Unaudited Financial Results for the Quarter and Nine Months Ended 31st December2023

  • 09 Feb 2024

    Board Meeting Outcome for Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter

    Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended 31st December 2023.

  • 17 Jan 2024

    Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended... More>

  • 10 Jan 2024

    Business Update

    Business Update

  • 19 May 2025

    Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results For The Quarter / Financial Year Ended March 31 2025 And To Discuss The Matter Of Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter /financial year ended March 31 2025 and to discuss the matter of recommendation of dividend if any for the financial year ended March 31 2025

  • 12 May 2025

    Intimation To The Holders Of Physical Securities To Furnish KYC Details

    Intimation to the holders of Physical Securities to furnish KYC details

  • 30 Apr 2025

    Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015

    Intimation under Regulation 30 of SEBI (LODR) Regulations 2015

  • 15 Apr 2025

    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1 Name of Company 3B BlackBio Dx Ltd
    2 CIN NO. L24211MP1972PLC001131
    3 Report filed for FY 2024-2025
    Details of the Current block (all figures in Rs crore):
    4 2 - year block period (Specify financial years)* NA
    5 Incremental borrowing done in FY (T)(a) 0.00
    6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
    7 Actual borrowing done through debt securities in FY (T)(c) 0.00
    8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
    8Quantum of (d) which has been met from (c)(e)* 0
    9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


    Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
    2 - year Block period (Specify financial years)NA
    Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



    Name of the Company Secretary :-Navneet Kaur
    Designation :-Company Secretary
    Name of the Chief Financial Officer :- Nikhil Kuber Dubey
    Designation : -CFO and Whole Time Director

    Date: 15/04/2025

  • 11 Apr 2025

    COMPLIANCE CERTIFICATE UNDER REGULATION 40(9) OF SEBI (LODR) REGULATIONS 2015 FOR THE YEAR ENDED 31-03-2025.

    Compliance Certificate under Reg 40(9) of SEBI (LODR) Regulations 2015 for the year ended 31-03-2025

  • 11 Apr 2025

    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1Name of Company3B BlackBio Dx Ltd
    2CIN NO.L24211MP1972PLC001131
    3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.31
    4Highest Credit Rating during the previous FY NA
    4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
    5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


    We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



    Name of the Company Secretary: Navneet Kaur
    Designation: Company Secretary
    EmailId: cs?kilpest.com
    Name of the Chief Financial Officer: Nikhil Kuber Dubey
    Designation: CFO and Whole Time Director
    EmailId: nikhilkuber?gmail.com

    Date: 11/04/2025

    Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

  • 09 Apr 2025

    Non Applicability Of Statement Of Deviation Or Variation Under Reg. 32(1) Of SEBI (LODR) Regulations 2015

    Non-Applicability of Statement of Deviation or variation under Reg. 32 (1) of SEBI (LODR) Regulations 2015

  • 03 Apr 2025

    Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011

    Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011

  • 25 Mar 2025

    Closure of Trading Window

    Closure of Trading Window

  • 24 Mar 2025

    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Mahesh Kumar Upadhyay

  • 22 Mar 2025

    Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations 2011

    Disclosure under Regulation 29(2) of SEBI (SAST) Regulations 2011

  • 03 Sep 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Advertisement

  • 02 Sep 2024

    Announcement under Regulation 30 (LODR)-Dividend Updates

    Dividend updates

  • 02 Sep 2024

    Reg. 34 (1) Annual Report.

    Annual Report for the FY 2023-24

  • 02 Sep 2024

    Notice Of 52Nd Annual General Meeting To Be Held On 24Th September2024

    Notice of 52nd Annual General meeting to be held on 24th September 2024

  • 02 Sep 2024

    52Nd Annual General Meeting On Tuesday 24Th September 2024

    52nd Annual General Meeting on Tuesday 24th September 2024

  • 02 Sep 2024

    Record Date And Date Of Book Closure For The Purpose Of Dividend And AGM

    Record Date and date of Book Closure for the purpose of Dividend and AGM

  • 28 Aug 2024

    Shareholders Update

    Shareholders Update

  • 24 Aug 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Publication

  • 23 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 22 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of duplicate share certificate under Reg 39 (3) of SEBI (LODR) Regulations 2015

  • 22 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 21 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 21 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    Schedule of Analyst / Investor meet - Outcome

  • 17 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 14 Aug 2024

    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    Schedule of Analysts / Institutional Investors meet(s) - Intimation

  • 13 Aug 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2024

  • 12 Aug 2024

    Unaudited Standalone And Consolidated Financial Results For Quarter Ended 30-06-24

    Unaudited Standalone and Consolidated Financial Results for quarter ended 30-06-24

  • 12 Aug 2024

    Board Meeting Outcome for Outcome Of Board Meeting Dt 12-08-2024

    Outcome of Board Meeting dt 12-08-2024

  • 12 Aug 2024

    Intimation Of Notice To Shareholders For Transfer Of Equity Shares To The Investor Education And Pro

    Intimation of Notice to Shareholders for transfer of Equity Shares to the Investor Education and Protection Fund (IEPF) Authority.

  • 12 Aug 2024

    Announcement under Regulation 30 (LODR)-Investor Presentation

    Investors Presentation

  • 10 Aug 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Disclosure under Regulation 30 of SEBI (LODR) Regulations2015-Newspaper Publication

  • 05 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 01 Aug 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding loss of share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 30 Jul 2024

    Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the company for the first quarter ended on 30th June2024

  • 09 Jul 2024

    Intimation To Holders Of Physical Securities To Furnish PAN KYC Details And Nomination As Per SEBI C

    Intimation to holders of physical securities to furnish PANKYC details and Nomination as per SEBI Circular

  • 05 Jul 2024

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

    Certificate under Reg 74(5) of SEBI (DP) Regulations2018

  • 04 Jul 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of Duplicate Share Certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 28 Jun 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Details of Loss of Certificate/Duplicate Certificate

  • 28 Jun 2024

    Closure of Trading Window

    Closure of Trading Window

  • 13 Jun 2024

    Clarification On Price Movement

    Clarification on Price Movement

  • 13 Jun 2024

    Clarification sought from 3B BlackBio Dx Ltd

    The Exchange has sought clarification from 3B BlackBio Dx Ltd on June 12 2024 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

    The reply is awaited.

  • 30 May 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Publication of Extract of Audited Financial Results for quarter and year ended 31-03-2024

  • 30 May 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Newspaper Publication of Extract of Audited Financial Results for the quarter and year ended 31-03-2024

  • 29 May 2024

    Submission Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31 M

    Submission of Audited Financial Results for the Quarter and Financial Year ended 31st March2024

  • 29 May 2024

    Board Meeting Outcome for Outcome Of BM

    Outcome of BM

  • 29 May 2024

    Announcement under Regulation 30 (LODR)-Dividend Updates

    Dividend update

  • 29 May 2024

    Announcement under Regulation 30 (LODR)-Dividend Updates

    Dividend update

  • 29 May 2024

    Board Meeting Outcome for Outcome Of BM

    Outcome of BM

  • 29 May 2024

    Investor Presentation

    Investor Presentation

  • 27 May 2024

    Compliances-Reg.24(A)-Annual Secretarial Compliance

    Annual Secretarial Compliance Report for the year ended 31-03-2024.

  • 09 May 2024

    Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015.

    Intimation under Regulation 30 of the SEBI (LODR) Regulations 2015.

  • 02 May 2024

    Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter / year ended March 31 2024 .

  • 27 Apr 2024

    Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

    Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1 Name of Company 3B BlackBio Dx Ltd
    2 CIN NO. L24211MP1972PLC001131
    3 Report filed for FY 2023-2024
    Details of the Current block (all figures in Rs crore):
    4 2 - year block period (Specify financial years)* 0
    5 Incremental borrowing done in FY (T)(a) 0.00
    6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
    7 Actual borrowing done through debt securities in FY (T)(c) 0.00
    8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
    8Quantum of (d) which has been met from (c)(e)* 0
    9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


    Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
    2 - year Block period (Specify financial years)0
    Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



    Name of the Company Secretary :-Navneet Kaur
    Designation :-Company Secretary
    Name of the Chief Financial Officer :- Nikhil Kuber Dubey
    Designation : -CFO and WholeTime Director

    Date: 27/04/2024

  • 27 Apr 2024

    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure

    Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

    Sr. No. Particulars Details
    1Name of Company3B BlackBio Dx Ltd
    2CIN NO.L24211MP1972PLC001131
    3 Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) 0.71
    4Highest Credit Rating during the previous FY NA
    4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable
    5Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the frameworkBSE


    We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No



    Name of the Company Secretary: Navneet Kaur
    Designation: Company Secretary
    EmailId: cs?kilpest.com
    Name of the Chief Financial Officer: Nikhil Kuber Dubey
    Designation: CFO and WholeTime Director
    EmailId: nikhilkuber?gmail.com

    Date: 27/04/2024

    Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

  • 15 Apr 2024

    Submission Of Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations 2015 For

    Submission of compliance certificate under Regulation 40(9) of the SEBI (LODR) Regulations 2015 for the financial year ended 31-03-2024

  • 08 Apr 2024

    Disclosure Under Reg 32(1) Of SEBI (LODR) Regulations2015

    Disclosure under Reg 32(1) of SEBI (LODR) Regualtions2015

  • 05 Apr 2024

    Compliance Certificate- Regulation 7(3) OF SEBI (LODR) Regulations 2015.

    Compliance Certificate - Regulation 7 (3) of SEBI (LODR) Regulations 2015

  • 05 Apr 2024

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

    Certificate under Reg. 74 (5) of the SEBI (DP) Regulations 2018

  • 02 Apr 2024

    Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011

    Disclosure Under Regulation 31(4) of SEBI (SAST) Regulations 2011

  • 27 Mar 2024

    Closure of Trading Window

    Closure of Trading Window

  • 13 Mar 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation of issue of Duplicate share certificate under Reg 39(3) of SEBI (LODR) Regulations 2015

  • 01 Mar 2024

    Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Intimation regarding Loss of Share Certificates under Regulation 39(3) of SEBI (LODR) 2015

  • 10 Feb 2024

    Announcement under Regulation 30 (LODR)-Newspaper Publication

    Submission of Advertisement Clipping of Extract of the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December2023.

  • 09 Feb 2024

    Investors Presentation

    Investors Presentation

  • 09 Feb 2024

    Unaudited Financial Results For The Quarter And Nine Months Ended 31St December 2023.

    Unaudited Financial Results for the Quarter and Nine Months Ended 31st December2023

  • 09 Feb 2024

    Board Meeting Outcome for Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter

    Outcome Of The Board Meeting- Unaudited Financial Results For The Quarter And Nine Months Ended 31st December 2023.

  • 17 Jan 2024

    Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Fin

    3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended 31st December 2023.

  • 10 Jan 2024

    Business Update

    Business Update

Download Our App On: